Compass Carter Osborne

Compass Carter Osborne is an executive search recruitment agency delivering award-winning leadership solutions to the private and investor-backed health, care, and life sciences sectors. Founded on deep sector expertise and a commitment to understanding client needs, the agency provides tailored executive search services, board advisory, interim executive placements, and leadership assessment across C-suite and senior management roles. The team comprises dedicated healthcare and life sciences experts with decades of combined search experience and an unparalleled track record of delivery, trusted repeatedly by the investment community to build outstanding leadership teams.

Compass Carter Osborne specialises across five core sectors: Healthcare, providing executive search to investor-backed primary and secondary care, consumer healthcare, and health and wellness providers; Social Care, delivering retained executive search across senior living, adult social care, and children's specialist education; Biopharmaceuticals, offering embedded talent solutions and C-suite executive search across the pharmaceutical and biotech industry globally; Medical Technologies, providing dedicated executive search services to the medical device, medtech, digital health, and software and systems markets; and Enabling Services, specialising in CRO, CDMO, and specialised service provider executive search across supply chain management, consultancy, agency, and business strategy businesses.

Compass Carter Osborne operates from its head office in London and expanded internationally with the opening of a New York office in April 2026, bringing specialist healthcare executive search to investor-backed markets across the United States. The agency is recognised for its results-driven approach, avoiding rigid processes in favour of bespoke solutions tailored to each client's specific requirements. Clients choose Compass Carter Osborne for its granular sector knowledge, emotionally intelligent consultants, responsive service, and consistent delivery, with the agency having received multiple awards for Search Firm of the Year since 2022 and recognition at the 2026 HealthInvestor Awards.